Scientific Committee
Independent reviewers who approve every asset's technical claims, TRL classification and validation evidence before listing.
Governance
Credibility is a process, not a claim.
Seven independent functions review every asset before it is listed, every valuation before it is published and every royalty statement before it is issued.
Board of Directors
Sets portfolio strategy, approves capital structures above threshold and appoints committee chairs.
Compliance
Third-party screening, conflict-of-interest register, anti-corruption controls and sanctions verification.
Ethics
Research ethics oversight, human and animal protocol review, responsible innovation guidelines.
Audit
Annual independent audit of royalty accounting, capital allocation and Lei do Bem dossiers.
LGPD & data protection
Data mapping, lawful-basis register, DPO channel and on-premise deployment options for clinical data.
Integrity policies
Code of conduct, whistleblowing channel with anonymity, supplier integrity due diligence.
Controls
What we commit to, operationally.
- No asset is listed without Scientific Committee approval of its TRL and evidence package.
- Valuation assumptions are documented, versioned and available in the Data Room.
- Royalty accounting is audited annually by an independent firm.
- Conflicts of interest are declared and registered before any committee vote.
- Personal and clinical data are processed under LGPD with on-premise options.
- An anonymous whistleblowing channel is available to all counterparties.